Intermittent preventive treatment with sulfadoxine-pyrimethamine versus intermittent screening and treatment of malaria in pregnancy
- Conditions
- Pregnancy and ChildbirthMalaria
- Registration Number
- PACTR201202000272122
- Lead Sponsor
- ondon School of Hygiene and Tropical Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 5000
1.Presence of a first or second pregnancy.
2.Gestation between 16 to 30 weeks inclusive at first booking as determined by symphysio-fundal measurements.
3.Provision of written informed consent to join the trial.
4. Residence in the study area and intention to stay in the area for the duration of the pregnancy.
1.Absence of informed consent.
2.An intention to leave the study area before delivery.
3.A history of sensitivity to sulphonamides.
4.Clinical AIDS or known HIV positivity.
5.Presence of any systemic illness likely to interfere with interpretation of the results of the trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.